ANEB
Anebulo Pharmaceuticals (ANEB)
$07
About Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Details
Daily high
$1.10
Daily low
$1.06
Price at open
$1.10
52 Week High
$3.42
52 Week Low
$0.90
Market cap
44.0M
Dividend yield
0.00%
Volume
1,009
Avg. volume
70,148
P/E ratio
-4.55
Anebulo Pharmaceuticals News
Details
Daily high
$1.10
Daily low
$1.06
Price at open
$1.10
52 Week High
$3.42
52 Week Low
$0.90
Market cap
44.0M
Dividend yield
0.00%
Volume
1,009
Avg. volume
70,148
P/E ratio
-4.55